Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma
Background.
In the United States, nearly 30% of liver transplants (LT) are performed for hepatocellular carcinoma (HCC). Although overall long-term survival is highest with LT, there are limited data on the incremental survival benefit of LT versus other curative options (resection or ablation) due to shunting of patients towards LT.
Methods.
We performed a retrospective cohort study of patients aged 50–69 with cirrhosis and HCC in the Veterans Health Administration (population enriched with 3 curative treatments) from 2008 to 2016. The cohort was restricted to patients who received LT, resection, or ablation and a calculated model for end-stage liver disease score
Source: Transplantation - Category: Transplant Surgery Tags: Original Clinical Science—Liver Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Liver Transplant | Study | Transplant Surgery | Transplants | Urology & Nephrology | USA Health